MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Orthofix Medical Long-Term Debt 2011-2026 | OFIX
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt Orthofix Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157 M | 157 M | 93.1 M | 19.2 M | 19.9 M | - | - | - | - | - | - | - | 20 M | 20 M | 191 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 191 M | 19.2 M | 84.7 M |
Quarterly Long-Term Debt Orthofix Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157 M | 157 M | 157 M | 157 M | 112 M | 113 M | 115 M | 93.1 M | 70 M | 51 M | 45 M | 19.2 M | 19.4 M | - | 19.7 M | 19.9 M | 20 M | 20.2 M | 20.3 M | 22.3 M | 22.3 M | 100 M | 22.3 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 157 M | 19.2 M | 62.2 M |
Long-Term Debt of other stocks in the Medical devices industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abbott Laboratories
ABT
|
9.9 B | $ 102.87 | 0.48 % | $ 179 B |  USA |
 |
Align Technology
ALGN
|
88.2 M | $ 170.6 | -1.23 % | $ 12.8 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
71.3 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
34 M | - | - | $ 475 M | USA |
 |
Acutus Medical
AFIB
|
32.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
7.56 M | - | - | $ 3.31 B | USA |
 |
Alphatec Holdings
ATEC
|
501 M | $ 10.83 | -3.82 % | $ 1.63 B | USA |
 |
Aziyo Biologics
AZYO
|
3.59 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
2.93 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
430 K | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
48.4 M | $ 34.44 | 2.56 % | $ 1.59 B | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
ClearPoint Neuro
CLPT
|
49.1 M | $ 9.37 | 2.52 % | $ 265 M | USA |
 |
Accuray Incorporated
ARAY
|
124 M | $ 0.42 | 6.82 % | $ 43.2 M | USA |
 |
Cardiovascular Systems
CSII
|
1.33 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
1.06 M | - | -10.19 % | $ 1.99 M | USA |
 |
Cytosorbents Corporation
CTSO
|
16.7 M | $ 0.58 | 6.52 % | $ 36.1 M | USA |
 |
Delcath Systems
DCTH
|
835 K | $ 9.63 | 0.94 % | $ 345 M | USA |
 |
CryoLife, Inc.
CRY
|
290 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.11 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
11.9 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
1.1 M | $ 23.29 | -1.52 % | $ 197 M | USA |
 |
Bruker Corporation
BRKR
|
2.06 B | $ 36.76 | 1.88 % | $ 5.48 K | USA |
 |
Boston Scientific Corporation
BSX
|
11.1 B | $ 62.82 | 1.32 % | $ 93 B | USA |
 |
Conformis
CFMS
|
20.6 M | - | - | $ 16.4 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
154 K | - | 0.03 % | $ 1.58 B |  Israel |
 |
Edwards Lifesciences Corporation
EW
|
598 M | $ 81.05 | -0.26 % | $ 47.4 B | USA |
 |
CONMED Corporation
CNMD
|
834 M | $ 34.79 | -2.08 % | $ 1.08 B | USA |
 |
Misonix, Inc.
MSON
|
38.6 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
7.64 M | - | - | $ 111 M |  Canada |
 |
Second Sight Medical Products
EYES
|
17.1 M | - | -0.97 % | $ 54.4 M | USA |
 |
Intersect ENT, Inc.
XENT
|
63.6 M | - | - | $ 955 M | USA |
 |
Aethlon Medical
AEMD
|
337 K | $ 2.12 | -1.4 % | $ 3.31 M | USA |
 |
BIOLASE
BIOL
|
11.8 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
1.72 B | $ 12.03 | 1.43 % | $ 1.63 B | USA |
 |
Helius Medical Technologies
HSDT
|
12 K | $ 1.86 | 9.41 % | $ 1.13 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
760 M | $ 9.53 | -0.42 % | $ 734 M | USA |
 |
Inogen
INGN
|
14.3 M | $ 6.21 | -0.96 % | $ 165 M | USA |
 |
Inspire Medical Systems
INSP
|
30 M | $ 54.99 | 2.52 % | $ 1.61 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
99.8 M | $ 16.06 | -1.41 % | $ 377 M | USA |
 |
IRIDEX Corporation
IRIX
|
98 K | $ 0.98 | 3.17 % | $ 16.6 M | USA |
 |
Invacare Corporation
IVC
|
354 M | - | - | $ 24.7 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.19 B | $ 86.85 | 0.47 % | $ 3.02 B | USA |
 |
LivaNova PLC
LIVN
|
345 M | $ 63.79 | -1.3 % | $ 3.48 B |  Britain |
 |
LENSAR
LNSR
|
1.99 M | $ 6.06 | 1.51 % | $ 72.5 M | USA |